Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC)

European Journal of Surgical Oncology

Volumn 38, Issue 1, 2012, Pages 88-94

  Schierl, R ^a   Novotna, J ^a   Piso, P ^b   Bohlandt A ^a   Nowak, D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Barmherzige Brüder Hospital   (Germany)

Author keywords

Environmental monitoring; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Platinum; Protective gloves

Indexed keywords

CISPLATIN; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY; CLEANING; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; GERMANY; GLOVE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MEDICAL INSTRUMENTATION; OPERATING ROOM; PRIORITY JOURNAL; SYRINGE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; ENVIRONMENTAL MONITORING; EQUIPMENT CONTAMINATION; FEMALE; GERMANY; GLOVES, PROTECTIVE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OPERATING ROOMS; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS;

EID: 83955161678     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.10.009     Document Type: Article

References (25)

1. G. Glockzin, H.J. Schlitt, and P. Piso Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy World J Surg Oncol 7 2009 5
2. P.H. Sugarbaker Surgical responsibilities in the management of peritoneal carcinomatosis J Surg Oncol 101 2010 713 724
3. O. Glehen, E. Cotte, and S. Kusamura Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion J Surg Oncol 98 2008 242 246
4. J.H. Stewart, P. Shen, and E.A. Levine Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies Expert Rev Anticancer Ther 8 2008 1809 1818
5. P.H. Sugarbaker Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis Semin Surg Oncol 14 1998 254 261 (Pubitemid 28146518)
6. P.H. Sugarbaker Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy Int J Hyperthermia 23 2007 431 442 (Pubitemid 47272773)
7. F. Mohamed, T. Cecil, B. Moran, and P. Sugarbaker A new standard of care for the management of peritoneal surface malignancy Curr Oncol 18 2011 e84 96
8. L. Maggiori, and D. Elias Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends Eur J Surg Oncol 36 2010 599 603
9. P. Piso, M.H. Dahlke, and N. Ghali Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies Int J Colorectal Dis 22 2007 1295 1300 (Pubitemid 47456713)
10. D. Elias, J.H. Lefevre, and J. Chevalier Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 2009 681 685
11. E.A. Levine, Stewart JHt, G.B. Russell, K.R. Geisinger, B.L. Loggie, and P. Shen Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures J Am Coll Surg 204 2007 943 953 discussion 53-5 (Pubitemid 46661217)
12. P.J. Sessink, K.A. Boer, A.P. Scheefhals, R.B. Anzion, and R.P. Bos Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers Int Arch Occup Environ Health 64 1992 105 112
13. A. Pethran, R. Schierl, K. Hauff, C.H. Grimm, K.S. Boos, and D. Nowak Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations Int Arch Occup Environ Health 76 2003 5 10 (Pubitemid 36740714)
14. L. Gonzalez-Bayon, S. Gonzalez-Moreno, and G. Ortega-Perez Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion Eur J Surg Oncol 32 2006 619 624 (Pubitemid 44064004)
15. S.K. White, A.D. Stephens, and P.H. Sugarbaker Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations AORN J 63 1996 716 724
16. O.A. Stuart, A.D. Stephens, L. Welch, and P.H. Sugarbaker Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C Ann Surg Oncol 9 2002 186 191 (Pubitemid 34259706)
17. T.H. Connor, P. Van Balen, and P.J. Sessink Monitoring for hazardous drugs in the operating room Ann Surg Oncol 10 2003 821 822 reply 2-3 (Pubitemid 40486883)
18. K. Schmid, M.I. Boettcher, and J.O. Pelz Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C Eur J Surg Oncol 32 2006 1222 1225 (Pubitemid 44774394)
19. R. Schierl, A. Bohlandt, and D. Nowak Guidance values for surface monitoring of antineoplastic drugs in German pharmacies Ann Occup Hyg 53 2009 703 711
20. A.S. Ensslin, A. Pethran, R. Schierl, and G. Fruhmann Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs Int Arch Occup Environ Health 65 1994 339 342 (Pubitemid 24083182)
21. IARC (International Agency for Research on Cancer) Monographs on the evaluation of carcinogenic risks to humans Overall evaluations of carcinogenity: an updating of IARC monographs volumes 1 to 42, Supplement 7 1987 Lyon, France
22. J.H. Stewart, P. Shen, and G. Russell A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers Ann Surg Oncol 15 2008 2137 2145
23. G. Korinth, K. Schmid, O. Midasch, M.I. Boettcher, J. Angerer, and H. Drexler Investigations on permeation of mitomycin C through double layers of natural rubber gloves Ann Occup Hyg 51 2007 593 600 (Pubitemid 351859258)
24. T.H. Connor, J. Barek, and J. Cvacka Permeability of nitrile rubber, latex, polyurethane, and neoprene gloves to 18 antineoplastic drugs Am J Health Syst Pharm 56 1999 2450 2453
25. P.E. Wallemacq, A. Capron, R. Vanbinst, E. Boeckmans, J. Gillard, and B. Favier Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions Am J Health Syst Pharm 63 2006 547 556